Related content

An automated drug delivery system for focal epilepsy

By Stein A.G.   Eder H.G.   Blum D.E.   Drachev A.   Fisher R.S.  

Epilepsy Research, Vol. 39, Iss. 2, 2000-04 ,pp. : 103-114

Elsevier

Access to resources Recommend Favorite

Screening for Mental Illness: The Merger of Eugenics and the Drug Industry

By Hassner Sharav Vera  

Ethical Human Psychology and Psychiatry, Vol. 7, Iss. 2, 2005-06 ,pp. : 111-124

Springer Publishing Company

Access to resources Recommend Favorite

Novel approaches to models of Alzheimer’s disease pathology for drug screening and development

By Shaughnessy Laura   Chamblin Beth   McMahon Lori   Nair Ayyappan   Thomas Mary   Wakefield John   Koentgen Frank   Ramabhadran Ram  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 23-32

Humana Press, Inc

Access to resources Recommend Favorite

Electrophysiology of the Guillain-Barre syndrome

By Cornblath D.R.  

Electroencephalography and Clinical Neurophysiology, Vol. 103, Iss. 1, 1997-07 ,pp. : 7-7

Elsevier

Access to resources Recommend Favorite

Update on electrophysiology in schizophrenia

By Mccarley Robert W.   O'Donnell Brian F.   Niznikiewicz Margaret A.   Salisbury Dean F.   Potts Geoffrey F.   Hirayasu Yoshio   Nestor Paul G.   Shenton Martha E.  

International Review of Psychiatry, Vol. 9, Iss. 4, 1997-12 ,pp. : 373-386

Informa Healthcare

Access to resources Recommend Favorite